Advertisement
Advertisement
Teikoku Sen-i Co., Ltd. (3302.T)
Tokyo - Tokyo Delayed Price. Currency in JPY
Follow
At close: 03:15PM JST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 1,531.00 |
| Open | 1,534.00 |
| Bid | 1,522.00 x 0 |
| Ask | 1,526.00 x 0 |
| Day's Range | 1,522.00 - 1,535.00 |
| 52 Week Range | 1,393.00 - 2,058.00 |
| Volume | |
| Avg. Volume | 83,321 |
| Market Cap | 40.415B |
| Beta (5Y Monthly) | 0.64 |
| PE Ratio (TTM) | 9.19 |
| EPS (TTM) | 165.99 |
| Earnings Date | Feb 14, 2023 |
| Forward Dividend & Yield | 45.00 (2.93%) |
| Ex-Dividend Date | Dec 29, 2022 |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Subscribe to Yahoo Finance Plus to view Fair Value for 3302.T
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Business Wire
Taro to Acquire Alchemee From Galderma
ZUG, Switzerland & HAWTHORNE, N.Y., February 22, 2022--Galderma and Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro") announced today they have signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company (TPC), from Galderma. The agreement between Galderma and Taro includes Alchemee’s business and assets around the world, including the Proactiv® brand.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
